Allogene Therapeutics (ALLO) Asset Utilization Ratio (2021 - 2024)

Allogene Therapeutics has disclosed Asset Utilization Ratio across 4 years of filings, most recently posting 0.0 for Q4 2024.

• Asset Utilization Ratio for Q4 2024 came in at 0.0, down 72.4% year-over-year; the trailing twelve-month figure through Dec 2024 was 0.0 (down 72.4% YoY), and the FY2024 annual result was 0.0, down 71.54% from the prior year.
• Asset Utilization Ratio came in at 0.0 for Q4 2024 at Allogene Therapeutics, down from 0.0 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.11 in Q4 2021 to a low of 0.0 in Q4 2024.
• The 4-year median for Asset Utilization Ratio is 0.0 (2023), against an average of 0.03.
• Across the five-year window, Asset Utilization Ratio jumped 135.45% in 2022 and slumped 99.84% in 2023, its largest moves.
• Allogene Therapeutics' Asset Utilization Ratio stood at 0.11 in 2021, then sank by 99.83% to 0.0 in 2022, then retreated by 22.95% to 0.0 in 2023, then slumped by 72.4% to 0.0 in 2024.
• The last three Asset Utilization Ratio figures came in at 0.0 (Q4 2024), 0.0 (Q3 2024), and 0.0 (Q2 2024), per Business Quant data.